Filed: 5/15/2024ACC: 0001012975-24-000215
📋 What this filing means
EUCLIDEAN CAPITAL LLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $779.98M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$779.98M
Total AUM (reported)
23.50M
Total Shares
Allocation by class
TR UNIT$509.81M65.4%
MSCI INDIA ETF$125.11M16.0%
GOLD SHS$88.93M11.4%
COM$49.30M6.3%
CLASS A COM$5.45M0.7%
COM NEW$1.38M0.2%
*W EXP 08/01/203$5.2K0.0%
Portfolio Concentration
Top 3$723.85M92.8%
4–10$53.17M6.8%
11–25$2.96M0.4%
Top 3 weight
92.8%
Top 10 weight
99.6%
Voting Authority Distribution
Total shares with voting rights: 23.50M
Sole
Full voting authority
23.50M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
SPDR S&P 500 ETF TR
SOLEShares974.64K
TypeSH
Market value$509.81M
65.36%
Sole
974.64K
Shared
0.00
None
0.00
ISHARES TR
SOLEShares2.43M
TypeSH
Market value$125.11M
16.04%
Sole
2.43M
Shared
0.00
None
0.00
SPDR GOLD TR
SOLEShares432.27K
TypeSH
Market value$88.93M
11.40%
Sole
432.27K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares989.41K
TypeSH
Market value$13.60M
1.74%
Sole
989.41K
Shared
0.00
None
0.00
FOGHORN THERAPEUTICS INC
SOLEShares1.57M
TypeSH
Market value$10.56M
1.35%
Sole
1.57M
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares1.31M
TypeSH
Market value$7.87M
1.01%
Sole
1.31M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares657.90K
TypeSH
Market value$5.91M
0.76%
Sole
657.90K
Shared
0.00
None
0.00
23ANDME HOLDING CO
SOLEShares10.24M
TypeSH
Market value$5.45M
0.70%
Sole
10.24M
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$5.31M
0.68%
Sole
1.02M
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares2.63M
TypeSH
Market value$4.47M
0.57%
Sole
2.63M
Shared
0.00
None
0.00
NGM BIOPHARMACEUTICALS INC
SOLEShares992.17K
TypeSH
Market value$1.58M
0.20%
Sole
992.17K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares87.70K
TypeSH
Market value$1.38M
0.18%
Sole
87.70K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares170.83K
TypeSH
Market value$5.2K
<0.01%
Sole
170.83K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 974.64K | SH | $509.81M 65.36% | 974.64K | 0.00 | 0.00 |
ISHARES TRSOLE | MSCI INDIA ETF | 2.43M | SH | $125.11M 16.04% | 2.43M | 0.00 | 0.00 |
SPDR GOLD TRSOLE | GOLD SHS | 432.27K | SH | $88.93M 11.40% | 432.27K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 989.41K | SH | $13.60M 1.74% | 989.41K | 0.00 | 0.00 |
FOGHORN THERAPEUTICS INCSOLE | COM | 1.57M | SH | $10.56M 1.35% | 1.57M | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 1.31M | SH | $7.87M 1.01% | 1.31M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 657.90K | SH | $5.91M 0.76% | 657.90K | 0.00 | 0.00 |
23ANDME HOLDING COSOLE | CLASS A COM | 10.24M | SH | $5.45M 0.70% | 10.24M | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 1.02M | SH | $5.31M 0.68% | 1.02M | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 2.63M | SH | $4.47M 0.57% | 2.63M | 0.00 | 0.00 |
NGM BIOPHARMACEUTICALS INCSOLE | COM | 992.17K | SH | $1.58M 0.20% | 992.17K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 87.70K | SH | $1.38M 0.18% | 87.70K | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/203 | 170.83K | SH | $5.2K <0.01% | 170.83K | 0.00 | 0.00 |